PHK
Point72 Hong Kong Portfolio holdings
AUM
$1.44B
1-Year Return
47.42%
This Quarter Return
+4.24%
1 Year Return
+47.42%
3 Year Return
+223.1%
5 Year Return
+307.89%
10 Year Return
+1,071.81%
AUM
$274M
AUM Growth
+$80.3M
(+41%)
Cap. Flow
+$83.3M
Cap. Flow
% of AUM
30.38%
Top 10 Holdings %
Top 10 Hldgs %
52.53%
Holding
1,369
New
478
Increased
184
Reduced
207
Closed
490
Top Buys
| 1 |
Baidu
BIDU
|
+$34.9M |
| 2 |
Wynn Resorts
WYNN
|
+$17.7M |
| 3 |
Melco Resorts & Entertainment
MLCO
|
+$14.8M |
| 4 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$10.3M |
| 5 |
New Oriental
EDU
|
+$8.27M |
Top Sells
| 1 |
Vipshop
VIPS
|
+$30.5M |
| 2 |
Huazhu Hotels Group
HTHT
|
+$4.98M |
| 3 |
BZUN
Baozun
BZUN
|
+$4.12M |
| 4 |
Intel
INTC
|
+$2.32M |
| 5 |
Weibo
WB
|
+$1.81M |
Sector Composition
| 1 | Communication Services | 30.41% |
| 2 | Consumer Discretionary | 23.92% |
| 3 | Industrials | 9.26% |
| 4 | Consumer Staples | 7.42% |
| 5 | Technology | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Intellia Therapeutics
NTLA
$1.28B
| $7K | ﹤0.01% |
248
-2,817
| -92% | -$79.5K |
|
677
Northern Trust
NTRS
$24.6B
| $7K | ﹤0.01% |
72
-324
| -82% | -$31.5K |
|
678
SEI Investments
SEIC
$10.7B
| $7K | ﹤0.01% |
+115
| New | +$7K |
|
679
Smith & Wesson
SWBI
$390M
| $7K | ﹤0.01% |
+742
| New | +$7K |
|
680
Weis Markets
WMK
$1.76B
| $7K | ﹤0.01% |
+127
| New | +$7K |
|
681
Zymeworks
ZYME
$1.15B
| $7K | ﹤0.01% |
+466
| New | +$7K |
|
|
EGIO
682
DELISTED
Edgio, Inc. Common Stock
EGIO
| $7K | ﹤0.01% |
39
-28
| -42% | -$5.03K |
|
|
TWOU
683
DELISTED
2U, Inc.
TWOU
| $7K | ﹤0.01% |
+3
| New | +$7K |
|
684
Ambarella
AMBA
$3.61B
| $6K | ﹤0.01% |
146
-2,684
| -95% | -$110K |
|
685
Baker Hughes
BKR
$44.8B
| $6K | ﹤0.01% |
186
+27
| +17% | +$871 |
|
686
Celldex Therapeutics
CLDX
$1.61B
| $6K | ﹤0.01% |
812
+776
| +2,156% | +$5.73K |
|
687
Collegium Pharmaceutical
COLL
$1.2B
| $6K | ﹤0.01% |
+269
| New | +$6K |
|
688
Entegris
ENTG
$12.3B
| $6K | ﹤0.01% |
167
+119
| +248% | +$4.28K |
|
689
Equitable Holdings
EQH
$15.8B
| $6K | ﹤0.01% |
+311
| New | +$6K |
|
690
JD.com
JD
$48B
| $6K | ﹤0.01% |
154
-3,920
| -96% | -$153K |
|
691
National Health Investors
NHI
$3.73B
| $6K | ﹤0.01% |
+78
| New | +$6K |
|
692
SM Energy
SM
$3B
| $6K | ﹤0.01% |
246
-3,880
| -94% | -$94.6K |
|
693
Spyre Therapeutics
SYRE
$1.01B
| $6K | ﹤0.01% |
+21
| New | +$6K |
|
694
Universal Health Services
UHS
$11.9B
| $6K | ﹤0.01% |
+52
| New | +$6K |
|
|
ACGN
695
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $6K | ﹤0.01% |
+33
| New | +$6K |
|
|
NUAN
696
DELISTED
Nuance Communications, Inc.
NUAN
| $6K | ﹤0.01% |
497
-1,075
| -68% | -$13K |
|
697
Babcock & Wilcox
BW
$203M
| $6K | ﹤0.01% |
+269
| New | +$6K |
|
698
Cadence Design Systems
CDNS
$98.6B
| $6K | ﹤0.01% |
130
-5,769
| -98% | -$266K |
|
699
Akebia Therapeutics
AKBA
$795M
| $5K | ﹤0.01% |
466
-4,383
| -90% | -$47K |
|
700
CDW
CDW
$22.1B
| $5K | ﹤0.01% |
59
-2,208
| -97% | -$187K |
|